Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
Meeraus W, Joy M, Ouwens M, Taylor KS, Venkatesan S, Dennis J, Tran TN, Dashtban A, Fan X, Williams R, Morris T, Carty L, Kar D, Hoang U, Feher M, Forbes A, Jamie G, Hinton W, Sanecka K, Byford R, Anand SN, Hobbs FDR, Clifton DA, Pollard AJ, Taylor S, de Lusignan S. Meeraus W, et al. Among authors: hobbs fdr. J Infect. 2024 Apr;88(4):106129. doi: 10.1016/j.jinf.2024.106129. Epub 2024 Feb 29. J Infect. 2024. PMID: 38431156 Free article.
Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: a pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales.
Kerr S, Bedston S, Bradley DT, Joy M, Lowthian E, Mulholland RM, Akbari A, Hobbs FDR, Katikireddi SV, de Lusignan S, Rudan I, Torabi F, Tsang RSM, Lyons RA, Robertson C, Sheikh A. Kerr S, et al. Among authors: hobbs fdr. Int J Epidemiol. 2023 Feb 8;52(1):22-31. doi: 10.1093/ije/dyac199. Int J Epidemiol. 2023. PMID: 36272418 Free PMC article.
Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort.
Joy M, Agrawal U, Fan X, Robertson C, Anand SN, Ordonez-Mena J, Byford R, Goudie R, Jamie G, Kar D, Williams J, Marsden GL, Tzortziou-Brown V, Sheikh SA, Hobbs FDR, de Lusignan S. Joy M, et al. Among authors: hobbs fdr. Lancet Reg Health Eur. 2023 Jul 18;32:100681. doi: 10.1016/j.lanepe.2023.100681. eCollection 2023 Sep. Lancet Reg Health Eur. 2023. PMID: 37671127 Free PMC article.
A targeted approach to vaccine hesitancy.
Leston M, de Lusignan S, Hobbs FDR. Leston M, et al. Among authors: hobbs fdr. Oxf Open Immunol. 2023 Oct 28;4(1):iqad007. doi: 10.1093/oxfimm/iqad007. eCollection 2023. Oxf Open Immunol. 2023. PMID: 38089637 Free PMC article.
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19).
Fanshawe TR, Tonner S, Turner PJ, Cogdale J, Glogowska M, de Lusignan S, Okusi C, Perera R, Sebastianpillai P, Williams A, Zambon M, Nicholson BD, Hobbs FDR, Hayward GN; RAPTOR-C19 Study Group. Fanshawe TR, et al. Among authors: hobbs fdr. Clin Microbiol Infect. 2024 Mar;30(3):380-386. doi: 10.1016/j.cmi.2023.12.009. Epub 2023 Dec 15. Clin Microbiol Infect. 2024. PMID: 38103638 Free article.
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales.
Bedston S, Almaghrabi F, Patterson L, Agrawal U, Woolford L, Anand SN, Joy M, Crawford A, Goudie R, Byford R, Abbasizanjani H, Smith D, Laidlaw L, Akbari A, Sullivan C, Bradley DT, Lyons RA, de Lusignan S, Hobbs FDR, Robertson C, Sheikh SA, Shi T. Bedston S, et al. Among authors: hobbs fdr. Lancet Reg Health Eur. 2023 Dec 12;37:100816. doi: 10.1016/j.lanepe.2023.100816. eCollection 2024 Feb. Lancet Reg Health Eur. 2023. PMID: 38162515 Free PMC article.
Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19).
Nicholson BD, Turner PJ, Fanshawe TR, Williams AJ, Amirthalingam G, Tonner S, Zambon M, Body R, Davies K, Perera R, de Lusignan S, Hayward GN, Hobbs FDR; RAPTOR-C19 Study Group and the CONDOR Steering Committee. Nicholson BD, et al. Among authors: hobbs fdr. PLoS One. 2023 Jul 21;18(7):e0288612. doi: 10.1371/journal.pone.0288612. eCollection 2023. PLoS One. 2023. PMID: 37478103 Free PMC article. Clinical Trial.
Development and external validation of a risk prediction model for falls in patients with an indication for antihypertensive treatment: retrospective cohort study.
Archer L, Koshiaris C, Lay-Flurrie S, Snell KIE, Riley RD, Stevens R, Banerjee A, Usher-Smith JA, Clegg A, Payne RA, Hobbs FDR, McManus RJ, Sheppard JP; STRAtifying Treatments In the multi-morbid Frail elderlY (STRATIFY) investigators. Archer L, et al. Among authors: hobbs fdr. BMJ. 2022 Nov 8;379:e070918. doi: 10.1136/bmj-2022-070918. BMJ. 2022. PMID: 36347531 Free PMC article.
Gut microbiology of UK care home residents: a cross-sectional analysis from a randomised controlled trial.
Gillespie D, Wootton M, Ray R, Calder PC, Mandy Lau TM, Owen-Jones E, Lowe R, Davies L, Richards J, Hood K, Castro-Herrera V, Davies J, Francis NA, Hobbs FDR, Lown M, Moore M, Shepherd V, Butler CC. Gillespie D, et al. Among authors: hobbs fdr. Clin Microbiol Infect. 2023 Nov;29(11):1437-1442. doi: 10.1016/j.cmi.2023.08.001. Epub 2023 Aug 17. Clin Microbiol Infect. 2023. PMID: 37595801 Free article. Clinical Trial.
320 results